Publications | Lund University Publications

1 – 5 of 5

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Holgate%2C+S%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Holgate%2C+S%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2008
Mark The Brussels Declaration: the need for change in asthma management
Holgate, S. ; Bisgaard, H. ; Bjermer, Leif ^LU ; Haahtela, T. ; Haughney, J. ; Horne, R. ; McIvor, A. ; Palkonen, S. ; Price, D. B. and Thomas, M. , et al. (2008) In European Respiratory Journal 32(6). p.1433-1442
- Contribution to journal › Article
2004
Mark Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
Holgate, S. T. ; Chuchalin, A. G. ; Hebert, J. ; Lotvall, J. ; Persson, Bo G ^LU ; Chung, K. F. ; Bousquet, J. ; Kerstjens, H. A. ; Fox, H. and Thirlwell, J. , et al. (2004) In Clinical and Experimental Allergy 34(4). p.632-638
- Contribution to journal › Article
2003
Mark Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma
Wallin, A ; Sue-Chu, M ; Bjermer, Leif ^LU ; Ward, J ; Sandstrom, T ; Lindberg, A ; Lundback, B ; Djukanovic, R ; Holgate, S and Wilson, S (2003) In Journal of Allergy and Clinical Immunology 112(1). p.72-78
- Contribution to journal › Article
2000
Mark Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)
Bjermer, Leif ^LU ; Bisgaard, H ; Bousquet, J ; Fabbri, L M ; Greening, A ; Haahtela, T ; Holgate, S T ; Picado, C and Leff, J A (2000) In Respiratory Medicine 94(6). p.612-621
- Contribution to journal › Article
1999
Mark Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society
Chung, K F ; Godard, P ; Adelroth, E ; Ayres, J ; Barnes, N ; Barnes, P ; Bel, E ; Burney, P ; Chanez, P and Connett, G , et al. (1999) In European Respiratory Journal 13(5). p.1198-1208
- Contribution to journal › Article